Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Galapagos NV ADR
GXEACurrent price
26.2 EUR
+0.2 EUR (+0.77%)
Last closed
29.3 USD
Company
www.glpg.com
ISIN
US36315X1019
Sector
Healthcare
Industry
Biotechnology
Exchange
Stuttgart Exchange
Capitalization
1 854 446 080 USD
Yield for 12 month
-16.11 %
1Y
3Y
5Y
10Y
15Y
GXEA
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Address: Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
32.64 USDP/E ratio
52.0377Dividend Yield
–Current Year
+264 648 606 USD
Last Year
+557 815 018 USD
Current Quarter
+85 969 619 USD
Last Quarter
+85 969 619 USD
Current Year
+264 622 110 USD
Last Year
+544 480 140 USD
Current Quarter
+67 691 153 USD
Last Quarter
+67 691 154 USD
Key Figures GXEA
1 year
3 years
5 years
10 years
EBITDA
-101 320 000 USD
Operating Margin TTM
PE Ratio
52.0377
Return On Assets TTM
-1.76 %
PEG Ratio
–
Return On Equity TTM
1.15 %
Wall Street Target Price
32.64 USD
Revenue TTM
261 402 000 USD
Book Value
44.16 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
29.7 %
Dividend Yield
–
Gross Profit TTM
4 818 000 USD
Earnings per share
0.53 USD
Diluted Eps TTM
0.53 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
74.8 %
Profit Margin
108.11 %
Dividend Analytics GXEA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GXEA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GXEA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
52.0377
Forward PE
166.6667
Enterprise Value Revenue
1.1836
Price Sales TTM
7.0942
Enterprise Value EBITDA
-31.4982
Price Book MRQ
0.5636
Financials GXEA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GXEA
For 52 weeks
24.16 USD
42.46 USD
50 Day MA
26.42 USD
Shares Short Prior Month
1 475 609
200 Day MA
32.08 USD
Short Ratio
13.39
Shares Short
1 509 172
Short Percent
3.07 %
BeatStart